Search company, investor...

Founded Year



Unattributed - II | Alive

Total Raised


About Tempus

Tempus is a company focused on precision medicine, operating within the healthcare and artificial intelligence sectors. The company offers services that utilize artificial intelligence to provide physicians with real-time, data-driven decisions for personalized patient care and targeted therapies. It also facilitates the discovery, development, and delivery of optimized therapeutic options for patients. It was founded in 2015 and is based in Chicago, Illinois.

Headquarters Location

600 West Chicago Avenue Suite 510

Chicago, Illinois, 60654,

United States



ESPs containing Tempus

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

Healthcare & Life Sciences / Monitoring, Imaging & Diagnostics Tech

The radiology AI — electrocardiogram (ECG) diagnostics market focuses on the development and adoption of AI-powered solutions designed to assist in the interpretation and analysis of electrocardiogram (ECG) data. ECG is a critical diagnostic tool for assessing the electrical activity of the heart, and AI applications in this market aim to improve the accuracy and efficiency of diagnosing cardiac c…

Tempus named as Leader among 13 other companies, including AliveCor,, and Anumana.

Tempus's Products & Differentiators


    Use our genomic platform to prospectively sequence through clinical trials and retrospectively support research priorities


Expert Collections containing Tempus

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Tempus is included in 10 Expert Collections, including Unicorns- Billion Dollar Startups.


Unicorns- Billion Dollar Startups

1,228 items


AI 100

99 items

Winners of CB Insights' annual AI 100, a list of the 100 most promising AI startups in the world.


Conference Exhibitors

5,501 items

HLTH is a healthcare event bringing together startups and large companies from pharma, health insurance, business intelligence, and more to discuss the shifting landscape of healthcare


Artificial Intelligence

10,987 items

Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.


Digital Health 50

300 items

The most promising digital health startups transforming the healthcare industry


Digital Health

10,585 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

Tempus Patents

Tempus has filed 138 patents.

The 3 most popular patent topics include:

  • molecular biology
  • oncology
  • genetics
patents chart

Application Date

Grant Date


Related Topics




Trees (data structures), Decision trees, Genetics, Classification algorithms, Biological databases


Application Date


Grant Date



Related Topics

Trees (data structures), Decision trees, Genetics, Classification algorithms, Biological databases



Latest Tempus News

Samsung Tapes Out 5G Networking SoC Design Using Cadence Quantus Extraction and Tempus Timing Solution

Dec 4, 2023 December 4, 2023  |  Editorial Team Cadence Design Systems, Inc.  has announced that  Samsung Foundry  successfully taped out a 5G networking SoC design on the Samsung 5LPE technology using the  Cadence Quantus Extraction Solution  and  Tempus Timing Solution . This accomplishment marks a turning point for Samsung Foundry where the team deployed the Cadence signoff solutions for the first time, achieving a 2X productivity boost that led to faster design closure versus its previous design methodology. The team also experienced significant power, performance and area (PPA) gains on this 120M instance design using the Cadence integrated flow. One of the most notable aspects of  Samsung Foundry ’s achievement was the team’s use of the Tempus ECO Option within the  Cadence Innovus Implementation System , which facilitated faster design convergence and closure, leading to an unprecedented reduction in project timeline. Further contributing to productivity improvement, Samsung Foundry deployed the Tempus hierarchical static timing analysis feature, enabling hierarchical design closure while optimizing resource allocation and reducing machine and memory demands. Lastly, the Samsung team utilized Tempus and Quantus distributed technology to curtail the overall runtime for this complex design. “The successful tape out of our SF5A design for 5G networking was a significant milestone for our team, and the enhanced efficiency and reduced runtime afforded by the Cadence Quantus Extraction Solution and Tempus Timing Solution are a testament to the power of innovation and collaboration between the  Cadence  and Samsung teams,” said Sangyun Kim, Vice president and head of Foundry Design Technology Team at Samsung Electronics, Samsung Electronics. “We’re committed to pushing the boundaries and leveraging the effectiveness of these signoff tools to deliver our designs to market faster, and we look forward to building upon our success for future projects and advancements.” “The integrated Quantus Extraction Solution and  Tempus Signoff Solution  played a pivotal role in enabling  Samsung Foundry  to achieve enhanced productivity and PPA gains and time-to-market efficiencies,” said Vivek Mishra, corporate vice president of the Digital & Signoff Group at  Cadence . “The most rewarding aspect of the collaboration with Samsung Foundry was seeing the team achieve their target design metrics while accelerating the time to market. We’re looking forward to continuing our work together to advance innovation.” The Quantus Extraction Solution and Tempus Signoff Solution are part of the broader  Cadence  digital full flow, offering a faster path to tape out. The tools and flow support the company’s Intelligent System Design strategy, enabling customers to achieve SoC design excellence.

Tempus Frequently Asked Questions (FAQ)

  • When was Tempus founded?

    Tempus was founded in 2015.

  • Where is Tempus's headquarters?

    Tempus's headquarters is located at 600 West Chicago Avenue, Chicago.

  • What is Tempus's latest funding round?

    Tempus's latest funding round is Unattributed - II.

  • How much did Tempus raise?

    Tempus raised a total of $1.345B.

  • Who are the investors of Tempus?

    Investors of Tempus include Ares Management, T. Rowe Price, Baillie Gifford, Novo Holdings, Franklin Templeton and 8 more.

  • Who are Tempus's competitors?

    Competitors of Tempus include Genetron Health, Holmusk, Atropos Health, OncoDNA, MedySapiens and 7 more.

  • What products does Tempus offer?

    Tempus's products include Sequencing and 4 more.

  • Who are Tempus's customers?

    Customers of Tempus include AstraZeneca, GSK, Genmab and Bayer.


Compare Tempus to Competitors

Owkin Logo

Owkin specializes in developing artificial intelligence (AI) technologies for clinical research and developing drugs and treatments for patients. It empowers researchers in hospitals, universities, and the biopharmaceutical industry to understand drug efficacy varies, improves the drug development process, and help identify key drugs and treatments for individual patients to improve patient outcomes. The company was founded in 2016 and is based in New York, New York.

Aetion Logo

Aetion operates as a healthcare analytics company. It provides decision-grade real-world evidence solutions to biopharma companies, payers, and regulatory agencies. It offers a platform that analyzes data from the real world to produce scientifically validated answers on treatments, effectiveness, and value. The company was founded in 2012 and is based in New York, New York.

ConcertAI Logo

ConcertAI is a healthcare technology company. It uses artificial intelligence (AI) to help oncologists make more informed treatment decisions for their patients. The platform analyzes large datasets of clinical and genomic data to identify patterns and insights which is used for personalized cancer treatment. It was formerly known as Precision HealthAI. It was founded in 2017 and is based in Cambridge, Massachusetts.

Caris Logo

Caris focuses on molecular science, specifically in the domain of cancer care. The company offers services such as molecular profiling, blood profiling, and tissue profiling, which provide comprehensive molecular information to help oncologists create personalized treatment plans for cancer patients. It primarily sells to the healthcare industry, particularly oncology. It was founded in 2008 and is based in Irving, Texas.

PathAI Logo

PathAI provides artificial intelligence (AI)-powered research tools and services for pathology. It delivers the diagnosis and treatment of cancer by leveraging modern approaches in machine learning. The company offers biopharmacy lab services, clinical development services, drug and diagnostic development, and more. It was founded in 2016 and is based in Boston, Massachusetts.

Pangea Biomed

Pangea Biomed develops a multi-cancer and multi-therapy response predictor. It combines machine learning and deep ribonucleic acid (RNA) analysis to map tumor molecular signatures for personalized cancer care. The company aims to bring precision oncology to cancer patients for the improvement of oncology drug development, and the empowerment of oncologists to treat patients. The company was founded in 2018 and is based in Tel Aviv, Israel.


CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.